RA
NVO

Range Advisory’s Novo Nordisk NVO Stock Holding History

Range Advisory’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Buy
+4,440
New +$191K 0.03% 326

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Range Advisory's NVO Position: Q2 2026 in Review

Range Advisory opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,440 shares worth $213K. The stake represents 0.03% of the portfolio and ranks #326 among its holdings.

1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Range Advisory held 4,440 shares of Novo Nordisk worth $213K as of Q2 2026.
  • Novo Nordisk was a new Range Advisory position in Q2 2026.
  • Novo Nordisk made up 0.03% of Range Advisory's portfolio in Q2 2026, its #326 holding.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Range Advisory's 13F filing for Q2 2026, filed 2 Sep 2026.